↓
 
  • Home
  • About Us
    • Funding Sources
    • Investigators
    • Research Staff
    • Research Trainees
    • Collaborators
    • Past Trainees
  • Projects
    • ABCD and Quality Improvement
    • Diabetes and Influenza
    • ADSS and Diabetes Surveillance
    • Cancer and Diabetes
    • Cardiovascular Disease and Diabetes
    • Mental Health and Diabetes
    • Health Behaviors & Diabetes Prevention/Management
    • Economic and Pharmaceutical Policy
    • Health-Related Quality of Life
    • Community-acquired pneumonia
    • Food accessibility during the COVID-19 pandemic
    • Alberta PROMs and EQ-5D Research and Support Unit
  • Dissemination
    • Making a difference…
    • Peer-reviewed Publications
    • Invited Commentaries
    • Presentations
  • Training Program
  • Links
  • News
    • Past Newsletters
    • Archived News
  • Meetings
    • DCRC
    • Research Retreats
      • Future ACHORD Retreats
      • Past ACHORD Retreats
    • Research Seminars
  • Contact Us
  • ABCD Study
    • About the Survey
    • Study Updates
    • Common Questions

Invited Commentaries

  • Johnson JA. Reflections on self-monitoring of blood glucose: Why do we recommend the things we do? Canadian Pharmacists Journal. 2010 Sep;143:216-217
  • Johnson JA, Yasui Y. Glucose-lowering therapies and cancer risk: The trials and tribulations of trials and observations. Diabetologia. 2010 Sept 1;53:1823-1826.
  • Johnson JA, Gale EA. Diabetes, insulin use, and cancer risk: are observational studies part of the solution-or part of the problem? Diabetes. 2010 May 1;59:1129-1131.
  • Butalia S, Rabi DM. To test or not to test? Self-monitoring of blood glucose in patients with type 2 diabetes managed without insulin. Open Medicine. 2010 1;4:E114-E116.
  • Rabi DM, Johnson JA, Edwards AL. Self-monitoring of blood glucose for individuals with type 2 diabetes not using insulin: Leaving no cornerstone unturned. Canadian Journal of Diabetes. 2010 Mar 1;34:24-26.
  • Johnson JA, Pollak M. Insulin, glucose and the increased risk of cancer in patients with type 2 diabetes. Diabetologia. 2010 Oct;53(10):2086-8. pp 2086–2088
  • Johnson JA, Colmers IN. Balancing the risks and benefits for pioglitazone in type 2 diabetes. Diabetes Research and Clinical Practice, 98(1) , October 2012, Pages 1-2
  • Johnson JA. The safety of sulfonylurea therapy in type 2 diabetes: have we reached the practical limits of our evidence base?Diabetologia. January 2015, Volume 58, Issue 1, pp 1–3
  • Eurich DT, McAlister FA. Wrongfully Accused: Metformin Use in Heart Failure. Comment on Aguilar et al. Metformin use and mortality in ambulatory patients with diabetes and heart failure. Circ Heart Failure 2011; 41:53-58.  Expert Rev Cardiovasc. Ther. 2011; 9(2): 147-150.
  • Eurich DT, Majumdar SR.  Statins and Sepsis – Scientifically Interesting but Clinically Inconsequential. Comment on Rothberg et al. Association Between Statins Given in Hospital and Mortality in Pneumonia Patients.  J. of Gen. Intern. Med. 2011, [Epub ahead of print]; J. of Gen. Intern. Med. 2011; 27(3):268-269

What’s New

 

Congratulations Lilla!

Congratulations to Lilla Roy for successfully completing her PhD Candidacy Examination. Great work Lilla!

Fall/Winter 2020 ACHORD Newsletter

Please click here to see what is new in ACHORD!

Pandemic Perspectives

Click here to read more on Pandemic Perspectives from our own Dean Eurich.

ACHORD Newsletter

Sign up to receive ACHORD news

ACHORD Twitter

Tweets by Ach0rd

ACHORD Calendar

March 2021
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
« Dec    
©2021 - - Weaver Xtreme Theme
↑